10.6.2024
7.6.2024
10
Jun
2024
Find more news and events
Suomeksi
In English
A screen study reveals that drugs reverting nuclear size changes in metastatic tumour cells also reduce the cell's increased ability to migrate.
Researchers at the University of Eastern Finland have used molecular modelling methods to investigate the movement of nano-sized plastics in membrane structures. The results indicate that for some microplastics, passive transport through the cell membrane may be a gateway into the cell.
Childhood is a fracture-prone time. Fractures in growing bones are different from those in adults and require expert care. According to Professor Yrjänä Nietosvaara, there is still room for improvement in the treatment of children’s fractures.
A new study from the University of Eastern Finland and the University of Tübingen helps to explain what defines how long a drug molecule stays bound to its target.
Regular physical activity significantly changes the body’s metabolite profile, and many of these changes are associated with a lower risk of type 2 diabetes, a new study shows.
Most of the disease-modifying antirheumatic drugs were not associated with the risk of Parkinson's disease, a new register-based study shows. An exception was the use of chloroquine or hydroxychloroquine which associated with a lower risk.
Arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of insulin resistance and dyslipidaemia from a young age, a new study suggests.
“Coronary artery disease has, for a long time, been mainly treated with cholesterol-lowering drugs, but there is a need for other types of treatments as well. For example, new drugs could target pathogenic changes taking place in the arterial wall,” Professor Minna Kaikkonen-Määttä says.
The FIND trial found that taking a much higher dose of vitamin D than recommended for five years did not affect total mortality or the incidence of cardiovascular disease or cancer in older men and women.